About DCVC
DCVC is a venture capital firm founded in 2011. It is primarily based out of Palo Alto, United States. As of Jun 2026, DCVC is an active investor, having invested in 378 companies, with 15 new investments in the last 12 months. It primarily invests in Series A round in United States based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to High Tech and Life Sciences. Most recently it participated in the $***** Series A round of Syntax Bio Overall, DCVC portfolio has seen 32 unicorns, 19 IPOs and 117 acquisitions including key companies like Uber, Facebook and Square. A lot of funds co-invest with DCVC, with names like SV Angel sharing a substantial percentage of its portfolio. DCVC has team of 39 people including 23 partners.Key Metrics
Team Members
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed, Series A & 6 more
Portfolio IPOs
Portfolio Unicorns
Portfolio Soonicorns
Deals in last 12 months
DCVC's List of Top Investments
DCVC has a portfolio of 378 companies, including 32 unicorns. Their most notable investments are in Verdigris and Alta Resource Technologies.Their portfolio spans across United States, United Kingdom, Canada and 18 more locations. They have invested in Enterprise Applications, High Tech, Life Sciences and 35 other sectors, across stages such as Seed, Series A and 6 more. Here is the list of top investments by DCVC:
1. Uber
Network providing on-demand transportation, delivery, and business management solutions. It facilitates ride requests and connects individuals with transportation providers. Additionally, it offers delivery services for food and other goods. The network extends to business solutions, providing tools for managing rides, meals, and local deliveries for organizations.
Key facts about Uber
- Founded Year: 2009
- Location: San Francisco (United States)
- Annual Revenue: $1B+ as on Dec 31, 2025
- Stage: Public
- Total Funding till date: $13.2B
- Employee Count: 152,642 as on May 31, 2026
- Investors: TrueBridge, Fidelity Investments and 191 Others
- Latest Funding Round: Post IPO, Dec 19, 2020, $*****
- Highlight: Public
2. Facebook
Operator of a social networking service facilitating connection and communication. Its services allows users to connect with friends, family, and other individuals. It provides tools for sharing updates, photos, and videos. The platform also offers features for creating and joining groups, following interests, and discovering content.
Key facts about Facebook
- Founded Year: 2004
- Location: Menlo Park (United States)
- Annual Revenue: $1B+ as on Dec 31, 2025
- Stage: Public
- Total Funding till date: $2.27B
- Employee Count: 26,594 as on May 31, 2026
- Investors: Sprout Capital Partners, TCV and 119 Others
- Latest Funding Round: Grant (prize money), Jan 15, 2017, $*****
- Highlight: Public
3. Square
Provider of integrated point of sale and business management solutions. The company delivers hardware and software for payments, retail, restaurants, and appointments. It offers tools for managing teams, payroll, marketing, customer relationships, and cash flow. The business provides solutions for various industries, including food and beverage, retail, beauty, and services.
Key facts about Square
- Founded Year: 2009
- Location: San Francisco (United States)
- Annual Revenue: $1B+ as on Dec 31, 2025
- Stage: Public
- Total Funding till date: $520M
- Employee Count: 6,412 as on May 31, 2026
- Investors: Saints Capital, TDM Growth Partners and 59 Others
- Latest Funding Round: Post IPO, Mar 03, 2020, $*****
- Highlight: Public
4. Gusto
Cloud-based payroll, benefits, and HR software for small and medium-sized businesses. Its core offering is software delivered online, with API integrations and automation features designed to help SMBs manage back-office operations more efficiently.
Key facts about Gusto
- Founded Year: 2012
- Location: San Francisco (United States)
- Valuation: $*****
- Stage: Series E
- Total Funding till date: $718M
- Employee Count: 4,426 as on May 31, 2026
- Investors: Western Technology Investment, Glynn Capital and 84 Others
- Latest Funding Round: Series E, May 13, 2022, $*****
- Highlight: Editors' Pick
5. Fortinet
Provider of cybersecurity solutions, services, and threat intelligence for enterprises. It offers a platform delivering network and cloud security, unified SASE, and security operations. The company provides services such as incident response, managed detection, and security awareness training. It also delivers operational technology security, including secure networking and ruggedized products.
Key facts about Fortinet
- Founded Year: 2000
- Location: Sunnyvale (United States)
- Annual Revenue: $1B+ as on Dec 31, 2025
- Stage: Public
- Total Funding till date: $39M
- Employee Count: 16,279 as on May 31, 2026
- Investors: Meritech, World Innovation Lab and 16 Others
- Latest Funding Round: Venture Debt, Mar 02, 2004, $*****
- Highlight: Public
DCVC's Year-on-Year Investment Trends
DCVC has invested in 378 companies over the last 15 years, with an average of 16 new investments annually in the last 10 years. In 2025, it made 27 investments, while as of Jun 2026, it has made 15 investments in this year. Its most recent first time investment was in Syntax Bio and most recent follow-on round was in Kanvas Biosciences.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 10 | 5 | 15 |
2025 | 13 | 14 | 27 |
2024 | 11 | 14 | 25 |
2023 | 16 | 12 | 28 |
2022 | 11 | 18 | 29 |
2021 | 24 | 18 | 42 |
2020 | 15 | 18 | 33 |
2019 | 12 | 11 | 23 |
2018 | 15 | 16 | 31 |
2017 | 30 | 13 | 43 |
DCVC's Investments by Stage
DCVC has made 113 investments in Seed stage with an average round size of $15.6M, 112 investments in Series A stage with an average round size of $21.3M and 23 investments in Series B stage with an average round size of $44M.Stage of entry | No. of Investments |
|---|---|
Seed | 113 |
Series A | 112 |
Series B | 23 |
Series C | 8 |
Series D | 6 |
Others | 3 |
Note: We have considered here, only first round of investments
DCVC's Investments by Sector
DCVC has a diverse portfolio, with companies operating in the Enterprise Applications, High Tech, Life Sciences, Enterprise Infrastructure and Sustainability Tech. Notably, it has invested in 360 Tech companies, 338 Enterprise (B2B) companies, 237 Software companies and at least 124 companies focusing on Saas.Sector | No. of Investments |
|---|---|
Enterprise Applications | 140 |
High Tech | 99 |
Life Sciences | 57 |
Enterprise Infrastructure | 53 |
Sustainability Tech | 40 |
Others | 321 |
Note: We have considered here, only first round of investments
DCVC's Investments by Geography
DCVC has made most investments in United States (231), followed by United Kingdom where it has made 9 investments.Country | No. of Investments |
|---|---|
United States | 231 |
United Kingdom | 9 |
Canada | 6 |
Australia | 4 |
New Zealand | 3 |
Others | 13 |
Note: We have considered here, only first round of investments
DCVC's recent investments
DCVC has made 15 investments in 2026 so far. Syntax Bio and Syntaxbio.com are the latest among them.Here are the most recent investments by DCVC:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Jun 22, 2026 | United States | Series A | 2732 | ||
Jun 21, 2026 | Australia | Series A | 6718 | ||
Jun 16, 2026 | United States | Series C | 1039 | [+6] | |
Jun 11, 2026 | - | Seed | 5224 | [+4] | |
May 07, 2026 | United States | Series A | 9937 | [+2] |
Unicorns in DCVC's Portfolio
DCVC has 32 unicorns in its portfolio - Odyssey, Lunar Energy, humans& and others. The most recent unicorn in their portfolio is Odyssey. It became a unicorn in 2026, 1 years after DCVC first invested in it.Here is a list of unicorns in DCVC's portfolio:
Tracxn Score | Company | Short Description | Founded year | Sector | Location | Company Stage | First Investment/ Acquisition Details |
|---|---|---|---|---|---|---|---|
52 | Developer of multimodal artificial intelligence models for interactive world simulations | 2023 | Palo Alto | Series B | qlwurrb | ||
57 | Manufacturer of multiple renewable energy, electric vehicles, and consumer electronics products | 2013 | - | San Francisco | Series D | quqiwdq | |
38 | Developer of artificial intelligence models focused on human interaction research | 2025 | Redwood City | Seed | ruu{bpa | ||
60 | Developer of portable nuclear microreactors designed to replace diesel generators | 2019 | Los Angeles | Series D | wcsjwgv | ||
63 | Developer of artificial intelligence models for de novo molecular design | 2023 | San Francisco | Series B | {ltllgn |
IPOs and Publicly Listed companies in DCVC's Portfolio
19 of DCVC's portfolio companies have become public. Fervo Energy got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in May 2026 at marketcap of $7.45B and Enlitic got listed on the Australian Securities Exchange (ASX) at marketcap of $21.9M.Here are DCVC's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
May 13, 2026 | Aug 22, 2022 | Series C | 2636 | |
Dec 19, 2023 | Oct 28, 2014 | Seed | 7917 | |
Aug 08, 2022 | - | - | 7206 | |
Mar 02, 2022 | Mar 28, 2017 | Series A | 5147 | |
Sep 28, 2021 | Jul 11, 2014 | Seed | 3295 |
Acquired companies in DCVC's Portfolio
117 companies from DCVC's portfolio have been acquired. The most recent acquisition was Recycleye in Apr 2026 by Cpgrp for $*****.Here are DCVC's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Apr 14, 2026 | Feb 02, 2023 | Series A | 3254 | |
Feb 25, 2026 | Jun 20, 2025 | Series E | 1598 | |
Jan 15, 2026 | Apr 08, 2015 | Seed | 2726 | |
Dec 08, 2025 | Nov 06, 2014 | Series A | 9929 | |
Sep 10, 2025 | Jun 21, 2012 | Series A | 9025 |
_1590472586674.png?devicePixelRatio=2&height=20&width=20){kind=logo}
Team profile of DCVC
DCVC has a team of 39 members including 23 Partners, 4 Venture Partners and 5 Principals located in United States and Italy. DCVC's team sits on the board of 3 companies.Here is a list of top team members in DCVC:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | San Francisco | - | ||
Partner | Palo Alto | |||
Partner | San Francisco | - | ||
Partner | Oakland | |||
Partner | Hudson | |||
Partner | San Francisco | - | ||
Partner | - | - | ||
Partner | Boston | - | ||
Partner | San Francisco | - | ||
Partner | - | - | ||
Partner | Tampa | - |
Co-investors of DCVC
Over the past 15 years, 2216 investors have co-invested in DCVC's portfolio companies. This includes funds and angels.
- Invested before DCVC: Y Combinator, National Science Foundation and 362 others have invested in rounds before DCVC. There are 31 companies where Y Combinator has invested before DCVC and 12 companies where National Science Foundation has invested before DCVC.
- Top Co-investors of DCVC: 762 investors entered a company along with DCVC. These include investors like SV Angel (19 companies).
- Invested after DCVC: A total of 1090 investors have invested in DCVC's portfolio after their investments. Top Investors include Google Ventures (9 companies), Tiger Global Management (7 companies) and In-Q-Tel (7 companies).
Recent News related to DCVC
•
Atom Computing Secures $300 Million Funding for Fault-Tolerant Quantum Hardware DeploymentQuantum Computing Report•Jun 16, 2026•Atom Computing, Third Point Ventures, Cisco Investments, DCVC and 3 others
•
How Aviv Yahav became one of security’s most referenced independent researchersTech Funding News•Jun 11, 2026•Khosla Ventures, Vine Ventures, DCVC, Zealot Labs
•
Firgun backs Quantum Motion in GBP £62 million roundIT Brief UK•May 13, 2026•Firgun Ventures, Quantum Motion, DCVC
•
Quantum Motion Raises $160 Million Series C to Deliver Quantum Computing's "Transistor Moment"Financial Post•May 07, 2026•Quantum Motion, DCVC, KEMBARA, Robert Bosch Venture Capital and 5 others
•
Kanvas Biosciences Secures $48M Series A to Deliver Novel Microbiome Therapeutics to Cancer PatientsThe Joplin Globe•May 06, 2026•Kanvas Biosciences, Gates, DCVC, Lion Capital and 16 others
•
Latus Bio to Present New Data at ASGCT 2026 Supporting Investigational Gene Therapy Approaches for Huntington’s Disease and CLN2 DiseaseBusiness Wire•Apr 28, 2026•Latus, Modi Ventures, Hatch BioFund, Gaingels and 4 others
•
•
AgZen Secures $10 Million Series B to Fuel Rapid GrowthAgrigateglobal•Mar 13, 2026•AgZen, Syngenta Group, Syngenta, Astanor and 3 others
•
Syngenta Plans US$10 Billion Hong Kong IPO in Q2The Business Times•Feb 27, 2026•Syngenta, AgZen, Syngenta Group, Astanor and 2 others
•
Chariot Defense Announces $34M Series A led by AndreessenTMC•Feb 25, 2026•Chariot Defense, Andreessen Horowitz, Overmatch, Marlinspike and 7 others
